Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2517 participants
OBSERVATIONAL
2012-02-10
2019-05-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- Cancer and cancer treatments can cause symptoms and side effects. Pain, fatigue, and emotional distress are three common symptoms. Accurate reporting of these symptoms can improve treatment methods and outcomes. Even though symptom reporting is important to treatment, there is no method to collect and compare patient data from multiple cancer care centers. Researchers want to develop a method for collecting cancer patient symptom information from multiple centers. This method may help improve cancer treatment at hospitals and other care centers.
Objectives:
\- To collect patient-reported symptom information from multiple cancer care centers.
Eligibility:
* Individuals at least 21 years of age who were treated for breast or colon cancer in the past year.
* Participants will come from one of the participating cancer care centers.
Design:
* Participants will answer a short questionnaire about their symptoms during cancer treatment. Questions will ask about symptom severity and experiences. Other questions will ask how well the doctors and nurses managed the symptoms.
* Participant responses will be compared with other medical and personal information. This information may include cancer type, age at diagnosis, and type of treatment.
* Treatment will not be provided as part of this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
NCT00303914
Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients
NCT03178045
Evaluation of a Symptom and Needs Assessment for Patients With Cancer
NCT04014751
Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice
NCT01108315
Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
NCT01136824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Cancer and its treatment lead to symptoms and side effects. Pain, fatigue, and emotional distress are three of the most common and distressing symptoms. Patient report is the gold standard for assessing these symptoms and is critical to patient-centered care.
* Symptoms are often under-reported or under-treated leading to impairments in quality of life, functioning, and treatment adherence. Factors contributing to under-reporting/treatment occur within patients (e.g., fear of addiction to pain meds), providers (e.g., lack of training), and the healthcare system (e.g., under-insurance).
* A limited number of studies suggest that the burden symptoms falls unevenly on certain racial/ethnic, socioeconomic status (SES), and insurance status groups.
* Despite the importance of symptoms in cancer care, there is no method for systematically collecting patient reported data at institutional or national levels. Such a system could identify at risk groups, inform intervention, and ultimately improve quality of care.
* This study uses existing resources to design a cost-effective symptom surveillance system. The NCI Community Cancer Center Program (NCCCP) provides the infrastructure for efficiently conducting a multi-site pilot in a real-world setting with a diverse sample of patients. The Commission on Cancer s Rapid Quality Reporting System (RQRS) will automate sampling to minimize burden on the cancer center s staff, facilitate data collection during or soon after treatment, and protect patients personal identifiers. The survey instrument is based upon previously validated measures.
Objectives:
* To pilot a method for collecting patient reports of symptom-related experiences that could be used for surveillance at institutional and, in the future, population levels.
* To investigate disparities in symptom burden and management between racial/ethnic, SES, and health insurance status groups.
* To pilot the use of patient-reported symptom data for quality improvement of symptom management at participating cancer centers.
Eligibility:
* Diagnosed with Stage I-III breast or colon cancer as first primary cancer between February 2011 and January 2013
* Age of 21 years or older
* Received cancer care from one of 17 participating NCCCP Cancer Centers.
Design:
* This cross-sectional survey will collect reports of symptoms and related experiences from patients 3-12 months after cancer diagnosis via mailed questionnaire. A methodological experiment will randomize patients after the second mailing to compare telephone follow-up to a third mailing. Data on cost and Cancer Center staff time will be collected to provide scalable estimates of overall cost and examine cost-effectiveness of telephone follow-up.
* The study will provide prevalence estimates for various symptoms and symptom management items. More complex, model-based statistics will be used to investigate symptom disparities (Aim 2). For these models, outcomes will be either continuous (e.g., pain severity) or ordinal (e.g., symptom management items) and will be analyzed using Generalized Linear Mixed Models (GLMM) to take into account the two-level structure of the data (patients nested within Cancer Centers). We expect to enroll 2,550 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with Stage I-III breast or colon cancer as first primary cancer between February 2011 and January 2013
* Eligible for one of the RQRS breast or colon Quality of Care Indicators
* Age of 21 or older
* Not known to be deceased at the time of contact
The NCCCP is a network of 30 community hospitals in 22 states supporting cancer research and enhancing cancer care for patients close to home. Most cancer patients in the U.S. are diagnosed and treated at community hospitals; not in NCI Comprehensive Cancer Centers where much research is conducted. The National Cancer Institute Community Cancer Centers Program (NCCCP) is expanding cancer research and bringing advanced cancer treatments to patients in community hospitals in rural, suburban and inner-city areas.
This study is being conducted at the 16 pilot NCCCP sites that first entered the program in 2007. All 16 participate in RQRS. These 16 pilot sites are located in 14 states throughout the United States.
Exclusion Criteria
* Patient is deceased at the time of sampling
* Patient has Stage IV cancer
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Castro, R.N.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Joseph's Orange
Orange, California, United States
Penrose Cancer Center
Colorado Springs, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
Christiana Care Health Services
Newark, Delaware, United States
Northside Hospital
Atlanta, Georgia, United States
St. Joseph's/Candler Health System
Savannah, Georgia, United States
Our Lady of the Lake/ Mary Bird Perkins
Baton Rouge, Louisiana, United States
The Cancer Institute Catholic Health Initiatives
Towson, Maryland, United States
Billings Clinical Cancer Center
Billings, Montana, United States
CHI, St. Fancis
Grand Island, Nebraska, United States
CHI, Good Samaritan
Kearney, Nebraska, United States
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
Spartanburg Regional Hospital
Spartanburg, South Carolina, United States
Sanford Health
Sioux Falls, South Dakota, United States
Ascension Health Systems
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol. 2011 Apr 1;29(10):1280-9. doi: 10.1200/JCO.2010.32.1554. Epub 2011 Feb 28.
Banna GL, Collova E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferrau F. Anticancer oral therapy: emerging related issues. Cancer Treat Rev. 2010 Dec;36(8):595-605. doi: 10.1016/j.ctrv.2010.04.005. Epub 2010 Jun 8.
Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain. 2009 Dec;10(12):1187-204. doi: 10.1016/j.jpain.2009.10.002.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-C-N039
Identifier Type: -
Identifier Source: secondary_id
999912039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.